Aptus Capital Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.5M | Buy |
22,554
+3,879
| +21% | +$430K | 0.02% | 376 |
|
|
2025
Q1 | $2.09M | Buy |
18,675
+374
| +2% | +$41.9K | 0.02% | 382 |
|
|
2024
Q4 | $1.69M | Buy |
18,301
+10,038
| +121% | +$927K | 0.02% | 416 |
|
|
2024
Q3 | $693K | Buy |
8,263
+309
| +4% | +$25.9K | 0.01% | 476 |
|
|
2024
Q2 | $546K | Sell |
7,954
-807
| -9% | -$55.4K | 0.01% | 487 |
|
|
2024
Q1 | $642K | Sell |
8,761
-52,321
| -86% | -$3.83M | 0.01% | 453 |
|
|
2023
Q4 | $4.95M | Sell |
61,082
-80
| -0.1% | -$6.48K | 0.14% | 132 |
|
|
2023
Q3 | $4.58M | Sell |
61,162
-2,224
| -4% | -$167K | 0.12% | 137 |
|
|
2023
Q2 | $4.89M | Buy |
63,386
+59,286
| +1,446% | +$4.57M | 0.12% | 134 |
|
|
2023
Q1 | $340K | Sell |
4,100
-530
| -11% | -$44K | 0.01% | 370 |
|
|
2022
Q4 | $397K | Buy |
4,630
+191
| +4% | +$16.4K | 0.01% | 370 |
|
|
2022
Q3 | $274K | Buy |
+4,439
| New | +$274K | 0.01% | 393 |
|
|
2022
Q2 | – | Sell |
-2,869
| Closed | -$171K | – | 679 |
|
|
2022
Q1 | $171K | Buy |
+2,869
| New | +$171K | ﹤0.01% | 426 |
|
|
2020
Q3 | – | Sell |
-2,687
| Closed | -$206K | – | 455 |
|
|
2020
Q2 | $206K | Sell |
2,687
-1,088
| -29% | -$83.4K | 0.01% | 243 |
|
|
2020
Q1 | $282K | Sell |
3,775
-2,980
| -44% | -$223K | 0.02% | 219 |
|
|
2019
Q4 | $438K | Sell |
6,755
-23,445
| -78% | -$1.52M | 0.03% | 232 |
|
|
2019
Q3 | $1.91M | Sell |
30,200
-4,531
| -13% | -$287K | 0.11% | 89 |
|
|
2019
Q2 | $2.35M | Buy |
34,731
+3,179
| +10% | +$215K | 0.33% | 48 |
|
|
2019
Q1 | $2.05M | Buy |
31,552
+9,614
| +44% | +$625K | 0.35% | 56 |
|
|
2018
Q4 | $1.37M | Buy |
+21,938
| New | +$1.37M | 0.36% | 50 |
|